Breaking News Instant updates and real-time market news.

SMG

Scotts Miracle-Gro

$145.38 /

-2.95 (-1.99%)

07:08
07/29/20
07/29
07:08
07/29/20
07:08

Scotts Miracle-Gro board raises quarterly dividend 7% to 62c per share

ScottsMiracle-Gro said its Board of Directors approved payment of a special dividend of $5 per share and increased its regular quarterly dividend by 7 percent to 62c per share. Both dividends are payable September 10 to shareholders of record on August 27.

  • 29

    Jul

SMG Scotts Miracle-Gro
$145.38 /

-2.95 (-1.99%)

07/22/20 Truist
Scotts Miracle-Gro price target raised to $155 from $150 at SunTrust
07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
06/02/20 Cleveland Research
Scotts Miracle-Gro in position to raise FY20 guidance, says Cleveland Research
05/26/20
Fly Intel: Top five analyst downgrades

TODAY'S FREE FLY STORIES

Recommendations
Wesco price target raised to $65 from $60 at Raymond James » 07:42
08/14/20
08/14
07:42
08/14/20
07:42
WCC

Wesco

$47.19 /

+3.35 (+7.64%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WCC Wesco
$47.19 /

+3.35 (+7.64%)

WCC Wesco
$47.19 /

+3.35 (+7.64%)

07/17/20 Gordon Haskett
Leonard Green position in Wesco 'particularly interesting,' says Gordon Haskett
06/24/20 Baird
Wesco downgraded to Neutral from Outperform at Baird
06/24/20 KeyBanc
Wesco upgraded to Overweight on Anixter deal accretion at KeyBanc
06/23/20 KeyBanc
Wesco upgraded to Overweight from Sector Weight at KeyBanc
WCC Wesco
$47.19 /

+3.35 (+7.64%)

Hot Stocks
Ocugen expects workforce reduction to result in $2M in annualized cost savings » 07:41
08/14/20
08/14
07:41
08/14/20
07:41
OCGN

Ocugen

$0.62 /

+0.0214 (+3.57%)

In June 2020, after…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCGN Ocugen
$0.62 /

+0.0214 (+3.57%)

OCGN Ocugen
$0.62 /

+0.0214 (+3.57%)

06/01/20 H.C. Wainwright
H.C. Wainwright downgrades Ocugen to Neutral after OCU300 discontinuation
06/01/20 H.C. Wainwright
Ocugen downgraded to Neutral from Buy at H.C. Wainwright
03/30/20 H.C. Wainwright
H.C. Wainwright encouraged Ocugen's Phase 3 trial of OCU300 still on track
12/20/19 H.C. Wainwright
Ocugen initiated with a Buy at H.C. Wainwright
OCGN Ocugen
$0.62 /

+0.0214 (+3.57%)

OCGN Ocugen
$0.62 /

+0.0214 (+3.57%)

Initiation
Tractor Supply initiated with a Neutral at DA Davidson » 07:41
08/14/20
08/14
07:41
08/14/20
07:41
TSCO

Tractor Supply

$148.75 /

-0.38 (-0.25%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSCO Tractor Supply
$148.75 /

-0.38 (-0.25%)

TSCO Tractor Supply
$148.75 /

-0.38 (-0.25%)

06:48 Today DA Davidson
Tractor Supply initiated with a Neutral at DA Davidson
07/24/20 RBC Capital
Tractor Supply price target raised to $162 from $138 at RBC Capital
07/24/20 Loop Capital
Tractor Supply price target raised to $150 from $120 at Loop Capital
07/24/20 Morgan Stanley
Morgan Stanley cuts Tractor Supply to Equal Weight after 60% year-to-date rally
TSCO Tractor Supply
$148.75 /

-0.38 (-0.25%)

TSCO Tractor Supply
$148.75 /

-0.38 (-0.25%)

TSCO Tractor Supply
$148.75 /

-0.38 (-0.25%)

Recommendations
Avino Silver & Gold price target raised to $1.60 from $1.40 at Roth Capital » 07:40
08/14/20
08/14
07:40
08/14/20
07:40
ASM

Avino Silver & Gold Mines

$1.27 /

+0.075 (+6.28%)

Roth Capital analyst Joe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASM Avino Silver & Gold Mines
$1.27 /

+0.075 (+6.28%)

Hot Stocks
Ocugen sees cash sufficient to fund operations into 1Q21 » 07:40
08/14/20
08/14
07:40
08/14/20
07:40
OCGN

Ocugen

$0.62 /

+0.0214 (+3.57%)

Ocugen sold an aggregate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCGN Ocugen
$0.62 /

+0.0214 (+3.57%)

OCGN Ocugen
$0.62 /

+0.0214 (+3.57%)

06/01/20 H.C. Wainwright
H.C. Wainwright downgrades Ocugen to Neutral after OCU300 discontinuation
06/01/20 H.C. Wainwright
Ocugen downgraded to Neutral from Buy at H.C. Wainwright
03/30/20 H.C. Wainwright
H.C. Wainwright encouraged Ocugen's Phase 3 trial of OCU300 still on track
12/20/19 H.C. Wainwright
Ocugen initiated with a Buy at H.C. Wainwright
OCGN Ocugen
$0.62 /

+0.0214 (+3.57%)

OCGN Ocugen
$0.62 /

+0.0214 (+3.57%)

Hot Stocks
AstraZeneca reports pact with EC for supply of up to 400M doses of COVID vaccine » 07:39
08/14/20
08/14
07:39
08/14/20
07:39
AZN

AstraZeneca

$55.80 /

-0.05 (-0.09%)

AstraZeneca announced it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$55.80 /

-0.05 (-0.09%)

AZN AstraZeneca
$55.80 /

-0.05 (-0.09%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/31/20 Barclays
Barclays backs Overweight on AstraZeneca after Q2 results
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/29/20 Barclays
AstraZeneca price target raised to 9,300 GBp from 9,200 GBp at Barclays
AZN AstraZeneca
$55.80 /

-0.05 (-0.09%)

AZN AstraZeneca
$55.80 /

-0.05 (-0.09%)

AZN AstraZeneca
$55.80 /

-0.05 (-0.09%)

AZN AstraZeneca
$55.80 /

-0.05 (-0.09%)

Earnings
Ocugen reports Q2 EPS (19c), two est. (3c) » 07:39
08/14/20
08/14
07:39
08/14/20
07:39
OCGN

Ocugen

$0.62 /

+0.0214 (+3.57%)

"I am very proud of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCGN Ocugen
$0.62 /

+0.0214 (+3.57%)

OCGN Ocugen
$0.62 /

+0.0214 (+3.57%)

06/01/20 H.C. Wainwright
H.C. Wainwright downgrades Ocugen to Neutral after OCU300 discontinuation
06/01/20 H.C. Wainwright
Ocugen downgraded to Neutral from Buy at H.C. Wainwright
03/30/20 H.C. Wainwright
H.C. Wainwright encouraged Ocugen's Phase 3 trial of OCU300 still on track
12/20/19 H.C. Wainwright
Ocugen initiated with a Buy at H.C. Wainwright
OCGN Ocugen
$0.62 /

+0.0214 (+3.57%)

OCGN Ocugen
$0.62 /

+0.0214 (+3.57%)

Recommendations
Target price target raised to $160 from $150 at Raymond James » 07:38
08/14/20
08/14
07:38
08/14/20
07:38
TGT

Target

$134.82 /

+0.21 (+0.16%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGT Target
$134.82 /

+0.21 (+0.16%)

TGT Target
$134.82 /

+0.21 (+0.16%)

07:21 Today Wells Fargo
Wells Fargo prefers Target to Walmart ahead of earnings next week
06:46 Today DA Davidson
Target initiated with a Buy at DA Davidson
08/13/20 Baird
Target price target raised to $150 from $135 at Baird
08/12/20 JPMorgan
JPMorgan adds Target to Analyst Focus List, raises price target to $154
TGT Target
$134.82 /

+0.21 (+0.16%)

TGT Target
$134.82 /

+0.21 (+0.16%)

TGT Target
$134.82 /

+0.21 (+0.16%)

TGT Target
$134.82 /

+0.21 (+0.16%)

Earnings
Cancer Genetics reports Q2 EPS (82c) vs. (24c) last year » 07:38
08/14/20
08/14
07:38
08/14/20
07:38
CGIX

Cancer Genetics

$3.01 /

+0.04 (+1.35%)

Reports Q2 revenue $1.4M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGIX Cancer Genetics
$3.01 /

+0.04 (+1.35%)

CGIX Cancer Genetics
$3.01 /

+0.04 (+1.35%)

CGIX Cancer Genetics
$3.01 /

+0.04 (+1.35%)

Initiation
Walmart initiated with a Buy at DA Davidson » 07:38
08/14/20
08/14
07:38
08/14/20
07:38
WMT

Walmart

$131.83 /

+1.04 (+0.80%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WMT Walmart
$131.83 /

+1.04 (+0.80%)

WMT Walmart
$131.83 /

+1.04 (+0.80%)

07:21 Today Wells Fargo
Wells Fargo prefers Target to Walmart ahead of earnings next week
06:46 Today DA Davidson
Walmart initiated with a Buy at DA Davidson
07/30/20
Fly Intel: Top five analyst initiations
07/30/20 MKM Partners
BJ's Wholesale initiated with a Sell at MKM Partners
WMT Walmart
$131.83 /

+1.04 (+0.80%)

WMT Walmart
$131.83 /

+1.04 (+0.80%)

WMT Walmart
$131.83 /

+1.04 (+0.80%)

WMT Walmart
$131.83 /

+1.04 (+0.80%)

Upgrade
Spin Master upgraded to Buy from Hold at Jefferies » 07:37
08/14/20
08/14
07:37
08/14/20
07:37
SNMSF

Spin Master

$0.00 /

+ (+0.00%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNMSF Spin Master
$0.00 /

+ (+0.00%)

08/12/20 BMO Capital
Spin Master price target raised to C$25 from C$18 at BMO Capital
08/10/20 Scotiabank
Spin Master price target raised to C$28 from C$24.50 at Scotiabank
08/07/20 RBC Capital
Spin Master price target raised to C$30 from C$25 at RBC Capital
08/07/20 TD Securities
Spin Master price target raised to C$34 from C$31 at TD Securities
Recommendations
Purple Innovation price target raised to $28 from $19 at Raymond James » 07:37
08/14/20
08/14
07:37
08/14/20
07:37
PRPL

Purple Innovation

$24.33 /

-0.675 (-2.70%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRPL Purple Innovation
$24.33 /

-0.675 (-2.70%)

PRPL Purple Innovation
$24.33 /

-0.675 (-2.70%)

08/07/20 Wedbush
Purple Innovation price target raised to $27 from $17 at Wedbush
08/03/20
Fly Intel: Top five analyst initiations
08/03/20 Craig-Hallum
Purple Innovation initiated with a Buy at Craig-Hallum
07/28/20 Oppenheimer
Purple Innovation price target raised to $25 from $19 at Oppenheimer
PRPL Purple Innovation
$24.33 /

-0.675 (-2.70%)

  • 15
    May
  • 15
    Nov
PRPL Purple Innovation
$24.33 /

-0.675 (-2.70%)

PRPL Purple Innovation
$24.33 /

-0.675 (-2.70%)

Recommendations
Roth Capital maintains Buy on RedHill after 'noisy' quarter » 07:36
08/14/20
08/14
07:36
08/14/20
07:36
RDHL

RedHill Biopharma

$8.37 /

-0.81 (-8.82%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$8.37 /

-0.81 (-8.82%)

RDHL RedHill Biopharma
$8.37 /

-0.81 (-8.82%)

07/07/20 SMBC Nikko
RedHill Biopharma initiated with an Outperform at SMBC Nikko
02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
RDHL RedHill Biopharma
$8.37 /

-0.81 (-8.82%)

RDHL RedHill Biopharma
$8.37 /

-0.81 (-8.82%)

Hot Stocks
Nephros appoints Andy Astor as president, CEO » 07:36
08/14/20
08/14
07:36
08/14/20
07:36
NEPH

Nephros

$7.69 /

+0.04 (+0.52%)

Nephros announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEPH Nephros
$7.69 /

+0.04 (+0.52%)

NEPH Nephros
$7.69 /

+0.04 (+0.52%)

01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
10/24/19 Benchmark
Nephros initiated with a Speculative Buy at Benchmark
10/04/19 Maxim
Nephros initiated with a Buy rating at Maxim
NEPH Nephros
$7.69 /

+0.04 (+0.52%)

  • 31
    Jan
Hot Stocks
KemPharm participates in KP415 mid-cycle communication meeting with FDA » 07:35
08/14/20
08/14
07:35
08/14/20
07:35
KMPH

KemPharm

$0.21 /

+ (+0.00%)

KemPharm announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KMPH KemPharm
$0.21 /

+ (+0.00%)

KMPH KemPharm
$0.21 /

+ (+0.00%)

05/20/20 H.C. Wainwright
KemPharm price target lowered to $1.50 from $2.50 at H.C. Wainwright
09/05/19 H.C. Wainwright
H.C. Wainwright says KemPharm may have picked 'best possible' partner in GPC
09/05/19 Roth Capital
Roth Capital downgrades KemPharm to Neutral after Gurnet Point partnership
09/05/19 Roth Capital
KemPharm downgraded to Neutral from Buy at Roth Capital
KMPH KemPharm
$0.21 /

+ (+0.00%)

Upgrade
Qiagen upgraded to Buy from Hold at Deutsche Bank » 07:35
08/14/20
08/14
07:35
08/14/20
07:35
QGEN

Qiagen

$48.66 /

+0.24 (+0.50%)

, TMO

Thermo Fisher

$416.27 /

+0.02 (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QGEN Qiagen
$48.66 /

+0.24 (+0.50%)

TMO Thermo Fisher
$416.27 /

+0.02 (+0.00%)

QGEN Qiagen
$48.66 /

+0.24 (+0.50%)

07:11 Today Exane BNP Paribas
Qiagen upgraded to Outperform from Neutral at Exane BNP Paribas
03/04/20 Stifel
Qiagen deal a positive for Thermo Fisher, says Stifel
03/04/20 Berenberg
Qiagen downgraded to Hold from Buy at Berenberg
03/03/20 Piper Sandler
Danaher unlikely to make competing bid for Qiagen, says Piper Sandler
TMO Thermo Fisher
$416.27 /

+0.02 (+0.00%)

07/27/20 Argus
Thermo Fisher price target raised to $450 from $370 at Argus
07/23/20 Baird
Thermo Fisher price target raised to $436 from $352 at Baird
07/23/20 SVB Leerink
Thermo Fisher price target raised to $455 from $365 at SVB Leerink
07/23/20 BTIG
Thermo Fisher price target raised to $475 from $372 at BTIG
QGEN Qiagen
$48.66 /

+0.24 (+0.50%)

TMO Thermo Fisher
$416.27 /

+0.02 (+0.00%)

QGEN Qiagen
$48.66 /

+0.24 (+0.50%)

TMO Thermo Fisher
$416.27 /

+0.02 (+0.00%)

QGEN Qiagen
$48.66 /

+0.24 (+0.50%)

TMO Thermo Fisher
$416.27 /

+0.02 (+0.00%)

QGEN Qiagen
$48.66 /

+0.24 (+0.50%)

TMO Thermo Fisher
$416.27 /

+0.02 (+0.00%)

Options
Unusual call flow in option market yesterday » 07:35
08/14/20
08/14
07:35
08/14/20
07:35
SPCE

Virgin Galactic

$18.76 /

+0.59 (+3.25%)

, PRPL

Purple Innovation

$24.33 /

-0.675 (-2.70%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPCE Virgin Galactic
$18.76 /

+0.59 (+3.25%)

PRPL Purple Innovation
$24.33 /

-0.675 (-2.70%)

SPCE Virgin Galactic
$18.76 /

+0.59 (+3.25%)

07/13/20 Alembic Global
Virgin Galactic initiated with an Overweight at Alembic Global
03/24/20 Morgan Stanley
Morgan Stanley upgrades Virgin Galactic to Overweight after over 70% drop
03/24/20 Morgan Stanley
Virgin Galactic upgraded to Overweight from Equal Weight at Morgan Stanley
03/03/20 Morgan Stanley
Lead up to next lunar landings can have 'powerful impact,' says Morgan Stanley
PRPL Purple Innovation
$24.33 /

-0.675 (-2.70%)

08/07/20 Wedbush
Purple Innovation price target raised to $27 from $17 at Wedbush
08/03/20
Fly Intel: Top five analyst initiations
08/03/20 Craig-Hallum
Purple Innovation initiated with a Buy at Craig-Hallum
07/28/20 Oppenheimer
Purple Innovation price target raised to $25 from $19 at Oppenheimer
SPCE Virgin Galactic
$18.76 /

+0.59 (+3.25%)

PRPL Purple Innovation
$24.33 /

-0.675 (-2.70%)

  • 06
    Aug
  • 03
    Jun
  • 20
    May
  • 15
    May
  • 15
    Nov
SPCE Virgin Galactic
$18.76 /

+0.59 (+3.25%)

SPCE Virgin Galactic
$18.76 /

+0.59 (+3.25%)

PRPL Purple Innovation
$24.33 /

-0.675 (-2.70%)

SPCE Virgin Galactic
$18.76 /

+0.59 (+3.25%)

PRPL Purple Innovation
$24.33 /

-0.675 (-2.70%)

Recommendations
Zai Lab price target raised to $111 from $105 at Guggenheim » 07:33
08/14/20
08/14
07:33
08/14/20
07:33
ZLAB

Zai Lab

$81.50 /

+1.5 (+1.88%)

Guggenheim analyst Seamus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZLAB Zai Lab
$81.50 /

+1.5 (+1.88%)

ZLAB Zai Lab
$81.50 /

+1.5 (+1.88%)

07/09/20 Roth Capital
Turning Point agreement with Zai Lab favorable, says Roth Capital
07/08/20 Guggenheim
Zai Lab price target raised to $105 from $75 at Guggenheim
07/07/20 SVB Leerink
Zai Lab price target raised to $93 from $79 at SVB Leerink
07/06/20 Mizuho
Novocure has large growth opportunity in China, says Mizuho
ZLAB Zai Lab
$81.50 /

+1.5 (+1.88%)

  • 23
    Jan
Earnings
ContraFect reports Q2 EPS (88c), consensus (37c) » 07:33
08/14/20
08/14
07:33
08/14/20
07:33
CFRX

ContraFect

$5.16 /

-0.24 (-4.44%)

"We continued to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CFRX ContraFect
$5.16 /

-0.24 (-4.44%)

CFRX ContraFect
$5.16 /

-0.24 (-4.44%)

06/09/20
Fly Intel: Top five analyst initiations
06/09/20 Mizuho
ContraFect initiated with a Buy at Mizuho
06/08/20 Cantor Fitzgerald
ContraFect initiated with an Overweight at Cantor Fitzgerald
10/02/19 Piper Jaffray
Piper says design differentiates ContraFect trial from other antibiotic studies
CFRX ContraFect
$5.16 /

-0.24 (-4.44%)

  • 22
    May
  • 10
    Dec
CFRX ContraFect
$5.16 /

-0.24 (-4.44%)

CFRX ContraFect
$5.16 /

-0.24 (-4.44%)

Recommendations
Farfetch price target raised to $31 from $20.50 at BTIG » 07:33
08/14/20
08/14
07:33
08/14/20
07:33
FTCH

Farfetch

$26.38 /

+0.45 (+1.74%)

BTIG analyst Marvin Fong…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FTCH Farfetch
$26.38 /

+0.45 (+1.74%)

FTCH Farfetch
$26.38 /

+0.45 (+1.74%)

08/11/20 Credit Suisse
Farfetch price target raised to $29 from $20 at Credit Suisse
07/14/20 Oppenheimer
Farfetch price target raised to $23 from $16 at Oppenheimer
07/08/20 China Renaissance
Farfetch upgraded to Buy from Hold at China Renaissance
07/01/20 Deutsche Bank
Farfetch price target raised to $23 from $17 at Deutsche Bank
FTCH Farfetch
$26.38 /

+0.45 (+1.74%)

FTCH Farfetch
$26.38 /

+0.45 (+1.74%)

FTCH Farfetch
$26.38 /

+0.45 (+1.74%)

Recommendations
SharpSpring price target raised to $15 from $12 at Roth Capital » 07:32
08/14/20
08/14
07:32
08/14/20
07:32
SHSP

SharpSpring

$9.27 /

+0.26 (+2.89%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHSP SharpSpring
$9.27 /

+0.26 (+2.89%)

SHSP SharpSpring
$9.27 /

+0.26 (+2.89%)

07/22/20 Roth Capital
SharpSpring price target lowered to $12 from $14 at Roth Capital
04/15/20 Craig-Hallum
SharpSpring assumed with a Buy at Craig-Hallum
03/13/20 Lake Street
SharpSpring price target lowered to $14 from $17 at Lake Street
SHSP SharpSpring
$9.27 /

+0.26 (+2.89%)

SHSP SharpSpring
$9.27 /

+0.26 (+2.89%)

Recommendations
AMC Networks price target lowered to $27 from $31 at Guggenheim » 07:32
08/14/20
08/14
07:32
08/14/20
07:32
AMCX

AMC Networks

$24.88 /

-0.135 (-0.54%)

Guggenheim analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMCX AMC Networks
$24.88 /

-0.135 (-0.54%)

AMCX AMC Networks
$24.88 /

-0.135 (-0.54%)

08/07/20 Macquarie
AMC Networks upgraded to Outperform from Neutral at Macquarie
07/13/20
Fly Intel: Top five analyst initiations
07/13/20 Goldman Sachs
AMC Networks initiated with a Sell at Goldman Sachs
06/19/20 Macquarie
AMC Networks price target raised to $29 from $26 at Macquarie
AMCX AMC Networks
$24.88 /

-0.135 (-0.54%)

AMCX AMC Networks
$24.88 /

-0.135 (-0.54%)

AMCX AMC Networks
$24.88 /

-0.135 (-0.54%)

Earnings
Lithium Americas reports Q2 EPS (7c) vs. (7c) last year » 07:30
08/14/20
08/14
07:30
08/14/20
07:30
LAC

Lithium Americas

$7.35 /

+0.225 (+3.16%)

"We remain focused…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LAC Lithium Americas
$7.35 /

+0.225 (+3.16%)

LAC Lithium Americas
$7.35 /

+0.225 (+3.16%)

06/25/20 BMO Capital
Lithium Americas price target raised to C$5 from C$4.40 at BMO Capital
LAC Lithium Americas
$7.35 /

+0.225 (+3.16%)

Upgrade
MSG Networks upgraded to Neutral from Sell at Guggenheim » 07:30
08/14/20
08/14
07:30
08/14/20
07:30
MSGN

MSG Networks

$10.67 /

+0.06 (+0.57%)

Guggenheim analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSGN MSG Networks
$10.67 /

+0.06 (+0.57%)

06:22 Today Guggenheim
MSG Networks upgraded to Neutral from Sell at Guggenheim
06/25/20 Wolfe Research
MSG Networks initiated with an Underperform at Wolfe Research
06/09/20 Imperial Capital
MSG Networks price target raised to $13 from $12 at Imperial Capital
05/04/20 Guggenheim
MSG Networks price target lowered to $10 from $13 at Guggenheim
MSGN MSG Networks
$10.67 /

+0.06 (+0.57%)

Recommendations
BioMarin price target raised to $218 from $172 at Goldman Sachs » 07:29
08/14/20
08/14
07:29
08/14/20
07:29
BMRN

BioMarin

$116.75 /

-1.24 (-1.05%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMRN BioMarin
$116.75 /

-1.24 (-1.05%)

BMRN BioMarin
$116.75 /

-1.24 (-1.05%)

08/05/20 SVB Leerink
BioMarin price target raised to $140 from $130 at SVB Leerink
08/05/20 Barclays
BioMarin price target raised to $135 from $125 at Barclays
08/05/20 JPMorgan
BioMarin price target raised to $156 from $140 at JPMorgan
08/05/20 Cantor Fitzgerald
BioMarin shares can re-rate further despite 42% rally, says Cantor Fitzgerald
BMRN BioMarin
$116.75 /

-1.24 (-1.05%)

BMRN BioMarin
$116.75 /

-1.24 (-1.05%)

BMRN BioMarin
$116.75 /

-1.24 (-1.05%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.